1. 33 out of 34 post-liver transplant hepatitis C virus (HCV) patients treated with the trial regimen (ombitasavir, ABT-450/r, dasabuvir, ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Spread ...
Image: PD 1. A single-tablet regimen of ledipasvir and sofosbuvir produced high rates of sustained virologic response among patients with ...
Image: PD 1. Combination therapy of HCV protease inhibitor ABT-450, nonnucleoside polymerase inhibitor ABT-333, and NS5A inhibitor ABT-267 achieved high, ...
1. In patients with relapsing-remitting multiple sclerosis, treatment with interferon beta-1b significantly reduced the rate of multiple sclerosis exacerbations in ...
Image: PD 1. Fingolimod significantly reduced the number of relapses as compared to interferon beta-1a over a one-year period. 2. ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.